Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SMAD family member 4 (SMAD4) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the SMAD4 transcript that governs the post-transcriptional expression of the SMAD4 protein. As a central mediator of the transforming growth factor-beta (TGF-beta) signaling pathway, SMAD4 facilitates the translocation of SMAD complexes into the nucleus to regulate gene transcription involved in cell proliferation, differentiation, and apoptosis (UniProt P61371). The 3'-UTR contains multiple binding sites for microRNAs (miRNAs), such as miR-146a, miR-199a, and miR-224, which typically downregulate SMAD4 expression by inducing mRNA degradation or inhibiting translation (PubMed: 28656245, PubMed: 25670455). Dysregulation of this region or the miRNAs targeting it is frequently observed in various cancers, including pancreatic and colorectal carcinomas, where loss of SMAD4 function promotes epithelial-mesenchymal transition (EMT) and metastasis (PubMed: 22348011). In therapeutic contexts, the SMAD4 mRNA 3'-UTR is explored as a target for miRNA mimics or antisense oligonucleotides designed to restore or modulate SMAD4 levels in diseases like cancer and tissue fibrosis. However, targeting this region presents challenges due to the dual role of TGF-beta signaling as both a tumor suppressor and a promoter of progression, necessitating precise temporal and spatial control of SMAD4 expression.
MicroRNA-mediated gene silencing and translational repression
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMAD family member 4 mRNA 3'-untranslated region (SMAD4 mRNA 3'-UTR).